J&J
This article was originally published in The Rose Sheet
Executive Summary
Aveeno Facial Care sell-in contributed to first quarter 5% skin care sales increase (9% excluding currency), firm reports during analyst call April 17. Soy-based line began rolling out in mass outlets in March (1"The Rose Sheet" March 12, p. 3). Neutrogena and Clean & Clear also saw solid growth, J&J says. New Evian Affinity face and body care products in France contributed to gains; J&J is "evaluating opportunities" for Evian in other markets, including U.S. Formulated with patented technology "designed to address skin's essential needs by providing [it] with air, water and nutrients," collection debuted in March in alliance with French bottled water manufacturer Danone. J&J worldwide consumer segment sales grew 5.5% to $1.8 bil. in first quarter. Consolidated sales grew 6.5% to $7.79 bil.; net earnings jumped 14.2% to $1.5 bil
You may also be interested in...
Evian Affinity Skin Care Tests U.S. Waters On Drugstore.com
Johnson & Johnson appears to be testing the viability of its Evian Affinity skin care brand in the U.S. market through an exclusive launch on the e-commerce health and beauty site Drugstore.com
Evian Affinity Skin Care Tests U.S. Waters On Drugstore.com
Johnson & Johnson appears to be testing the viability of its Evian Affinity skin care brand in the U.S. market through an exclusive launch on the e-commerce health and beauty site Drugstore.com
J&J Neutrogena, RoC Extensions Aim To Fuel Skin Care Gains In Second Half
Neutrogena and RoC skin care launches planned for the second half of the year are expected to help Johnson & Johnson regain category growth following disappointing second quarter sales in the sector, the company said.